Shareholders Equity and Capital Stock (Details 7) - USD ($) |
3 Months Ended | |
|---|---|---|
Mar. 31, 2022 |
Dec. 31, 2021 |
|
| Warrants | ||
| Exercise Price | $ 1.17 | |
| Number Of Warrants | 23,850,530 | |
| Remaining Contractual Life (years) | 1 year 4 months 24 days | |
| Aggregate Intrinsic Value | $ 5,117,316 | |
| Exercise price $0.75 | ||
| Exercise Price | $ 0.75 | |
| Number Of Warrants | 7,120,000 | |
| Remaining Contractual Life (years) | 3 months 18 days | |
| Aggregate Intrinsic Value | $ 3,026,000 | |
| Expiry | Aug. 04, 2022 | |
| Exercise price $1.35 | ||
| Exercise Price | $ 1.35 | |
| Number Of Warrants | 16,730,530 | |
| Remaining Contractual Life (years) | 1 year 9 months 18 days | |
| Aggregate Intrinsic Value | $ 2,091,316 | |
| Expiry | Feb. 04, 2024 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|